LifeTech Scientific Corp (1302)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 23 Oct 2026
Key indicators
| Last close | HKD 1.520 |
|---|---|
| 52-week range | 1.255 – 2.380 |
| Return, 1 month / 3 months | +12.2% / −4.4% |
| Return, 1 year / 3 years | −28.3% / −33.9% |
| Trend | Below its 200-day average |
| RSI (14) | 62 |
| Volatility (1 year) | 55.1% |
| Worst drawdown (1 year) | -43.7% |
| Average daily value traded | 25.80M HKD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
LifeTech Scientific Corporation develops and manufactures minimally invasive medical devices for cardiovascular and peripheral vascular conditions. Its products include stents, delivery systems and implantable devices used in structural heart and vascular procedures. The company serves hospitals and clinicians in China and other markets, and it is based in Shenzhen, China. Its work centres on devices that treat heart and blood vessel disease through small incisions rather than open surgery.
LifeTech Scientific Corp trades under the code 1302 on the Hong Kong Stock Exchange in Hong Kong, with its price quoted in Hong Kong dollars (HKD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
LifeTech Scientific Corp (1302) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 1.520 on 23 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 1,106 of 2,613 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 28.3% and over the last three months it fell 4.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 52 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -5.8% | ||
| From 52-week high | -34.2% | ||
| Momentum | 42 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -4.4% | ||
| 6-month return | -19.1% | ||
| 12-month return, skipping the last month | -36.1% | ||
| Stability (higher is calmer) | 55 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 55.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -43.7% | ||
| Liquidity | 82 · Strong | Trades actively. | |
| Average daily value traded | 25.80M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +7.4% |
|---|---|
| 1 month | +12.2% |
| 3 months | −4.4% |
| 6 months | −19.1% |
| 1 year | −28.3% |
| 3 years | −33.9% |
| 5 years | −60.7% |
Signals
| 50-day / 200-day average | 1.379 / 1.614 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.075 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.